Literature DB >> 20152700

Myocardial contractile function in the region of the left ventricular pacing lead predicts the response to cardiac resynchronization therapy assessed by two-dimensional speckle tracking echocardiography.

Kazuko Norisada1, Hiroya Kawai, Hidekazu Tanaka, Kazuhiro Tatsumi, Tetsuari Onishi, Koji Fukuzawa, Akihiro Yoshida, Ken-ichi Hirata.   

Abstract

BACKGROUND: The aim of this study was to test the impact of posterolateral myocardial systolic function on response to cardiac resynchronization therapy (CRT).
METHODS: Forty patients were studied before and 4 +/- 2 months after CRT. Dyssynchrony was defined as anteroseptal wall-to-posterior wall delay (> or = 130 ms) caused by speckle-tracking radial strain. The average longitudinal strain in 4 posterior and lateral segments (epsilon-pl) in which the left ventricular pacing lead was positioned was calculated by automated functional imaging. Response to CRT was defined as a > or = 15% decrease in end-systolic volume.
RESULTS: The negative value of epsilon-pl in responders was significantly higher than that in nonresponders at baseline (-7.8 +/- 6.9% vs -2.1 +/- 4.9%, P < .01). Combining dyssynchrony with epsilon-pl < -7.8% was more effective for predicting response to CRT than dyssynchrony parameters alone (92% vs 75%).
CONCLUSION: The addition of posterolateral myocardial systolic function to the measurement of dyssynchrony appears to be of value for predicting response to CRT. Copyright 2010 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152700     DOI: 10.1016/j.echo.2009.11.017

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

Review 1.  Is speckle tracking actually helpful for cardiac resynchronization therapy?

Authors:  Hidekazu Tanaka; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2016-01-14

Review 2.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

3.  Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy.

Authors:  Chiara Cavallino; Elisa Rondano; Andrea Magnani; Lucia Leva; Eugenio Inglese; Gabriele Dell'era; Eraldo Occhetta; Miriam Bortnik; Paolo N Marino
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-19       Impact factor: 2.357

Review 4.  Longitudinal and circumferential strain in patients with regional LV dysfunction.

Authors:  Manish Bansal; Partho P Sengupta
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 5.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

6.  An automatic alignment tool to improve repeatability of left ventricular function and dyssynchrony parameters in serial gated myocardial perfusion SPECT studies.

Authors:  Yanli Zhou; Tracy L Faber; Zenic Patel; Russell D Folks; Alice A Cheung; Ernest V Garcia; Prem Soman; Dianfu Li; Kejiang Cao; Ji Chen
Journal:  Nucl Med Commun       Date:  2013-02       Impact factor: 1.690

7.  Strain dyssynchrony index determined by three-dimensional speckle area tracking can predict response to cardiac resynchronization therapy.

Authors:  Kazuhiro Tatsumi; Hidekazu Tanaka; Takayuki Tsuji; Akihiro Kaneko; Keiko Ryo; Kohei Yamawaki; Alaa M S Omar; Yuko Fukuda; Kazuko Norisada; Kensuke Matsumoto; Tetsuari Onishi; Akihiro Yoshida; Hiroya Kawai; Ken-ichi Hirata
Journal:  Cardiovasc Ultrasound       Date:  2011-04-05       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.